An open-label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
Latres E, Plum-Moerschel L, Murugesan SMN, et al.
Diabetes Obes Metab. Pub. online 10 Apr 2025.
Leggi